Navigation Links
Caliper Life Sciences Launches Microfluidic LabChip® DS Platform for UV/VIS Spectral Analysis of Nucleic Acid and Protein Samples

HOPKINTON, Mass., Jan. 31, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) announced today that Caliper and Trinean, NV have agreed to a long-term, exclusive arrangement under which Caliper will distribute Trinean's DropSense platform under the name LabChip DS in North America.

With the LabChip DS, an automated UV/Vis spectral analysis platform, users can easily and accurately analyze the concentration levels of up to 96 nucleic acid and protein samples within a few minutes. The LabChip DS complements Caliper's existing LabChip GX which provides fluorescent, electrophoretic analysis of fragments of nucleic acids and proteins.

"Caliper is investing significant resources into developing new products, applications on our existing products, and third party collaborations, co-marketing and distribution agreements to further augment our aggressive move into the biotherapeutics and genomics markets," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "Caliper has become a vendor and partner of choice for sequencing sample preparation tools, and we are very pleased to add Trinean's DropSense platform to the tools we offer to our customers in North America."

"The DropSense platform is a state-of-the-art polychromatic plate reader that provides pioneering concentration analysis of 0.5 to 3.0 microliter droplets of sample with substantial time savings and automation advantages to scientific researchers," said Marc Zabeau, CEO of Trinean. "Trinean is pleased to leverage Caliper's extensive commercial presence in the genomics and biologics markets in North America, as well as its experience in commercializing microfluidic technologies."

The LabChip DS complements Caliper's existing LabChip GXI and GXII platforms. The LabChip DS provides UV/Vis spectral analysis of the total concentration of nucleic acid or protein in a sample, whereas the GXI and GXII platforms provide size, quantification, and purity analysis of discrete fragments of nucleic acids and proteins in the sample. In a potential sequencing workflow, the LabChip DS is used for the initial concentration analysis of extracted genomic DNA. The genomic DNA would then be sheared using third party equipment, then size fractionated on a Caliper LabChip XT platform. Quality control analysis of the sheared DNA and constructed libraries would then be performed using the LabChip GXI platform to assess size, purity and amount of the DNA fragments.

In addition, preparation of samples for the LabChip DS platform can be performed on Caliper's liquid handling instruments, including the Sciclone® NGS Workstation, which is a robust, scalable platform that has been specifically customized for next generation sequencing methods, or Caliper's Zephyr® Genomics Workstation, which automates a broad range of standard molecular biology kits.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit

About Trinean

Trinean, a spin-off from the University of Ghent and IMEC, Belgium, is a pioneer in automated micro volume spectroscopy systems. Trinean's first product is the DropSense®96, a multichannel spectrophotometer, that combined with disposable microfluidic microplates (DropPlate®16 and DropPlate®96), provides a fully automated workflow system for quick & precise spectral analysis of microliter droplets of DNA, RNA, protein or small compounds. Trinean is a privately-owned company and has been supported by substantial research and development grants from the Flemish government. For more information please visit

Caliper, LabChip, Sciclone, and Zephyr are registered trademarks of Caliper Life Sciences, Inc. and DropSense and DropPlate are registered trademarks of Trinean, NV.

SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
2. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
3. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
4. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
5. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
6. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
7. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
8. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
9. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
10. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
11. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
Post Your Comments:
(Date:11/25/2015)... PUNE, India , November 26, 2015 /PRNewswire/ ... The Global Biobanking Market 2016 - 2020 ... biobanks by maintaining integrity and quality in long-term ... and enabling long-term cost-effectiveness. Automation minimizes manual errors ... improves the technical efficiency. Further, it plays a ...
(Date:11/25/2015)... 25, 2015 2 nouvelles études permettent ... les différences entre les souches bactériennes retrouvées dans la ... des êtres humains . Ces recherches  ouvrent une nouvelle ... prise en charge efficace de l,un des problèmes ... chats .    --> 2 nouvelles études ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
Breaking Biology Technology:
(Date:10/29/2015)... Oct. 29, 2015 Today, LifeBEAM ... partnership with 2XU, a global leader in technical ... smart hat with advanced bio-sensing technology. The hat ... to monitor key biometrics to improve overall training ... the two companies will bring together the most advanced ...
(Date:10/27/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leader ... adopted the Synaptics ® ClearPad ® Series ... newest flagship smartphones, the Nexus 5X by LG and ... --> --> Synaptics works closely with ... in the joint development of next generation technologies. Together, ...
(Date:10/26/2015)...  Delta ID Inc., a company focused on bringing ... devices, announced its ActiveIRIS® technology powers the iris recognition ... by NTT DOCOMO, INC in Japan ... to include iris recognition technology, after a very successful ... May 2015, world,s first smartphone to have this capability. ...
Breaking Biology News(10 mins):